Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.2, 2004-02, pp. : 161-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus suppresses cardiac-allograft vasculopathy

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Costs no higher with everolimus in heart transplant

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Everolimus evades acute rejection following renal transplant

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation

By Suzuki Jun-ichi Ogawa Masahito Hirata Yasunobu Nagai Ryozo Isobe Mitsuaki

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 783-789

Informa Healthcare

Access to resources Recommend Favorite

Strategies to Prevent Cellular Rejection in Pediatric Heart Transplant Recipients

By Denfield Susan W.

Pediatric Drugs, Vol. 12, Iss. 6, 2010-12 ,pp. : 391-403

Adis International

Access to resources Recommend Favorite